Cyclophosphamide (generic), Cytoxan Newswire (Page 3)

Cyclophosphamide (generic), Cytoxan Newswire (Page 3)

Comprehensive Real-Time News Feed for Cyclophosphamide (generic), Cytoxan. (Page 3)

Results 41 - 60 of 381 in Cyclophosphamide (generic), Cytoxan

  1. Sangamo Therapeutics - Part II: Is There A Hidden Asset In Play?Read the original story w/Photo

    Mar 8, 2018 | Seeking Alpha

    Never promote someone who hasn't made some bad mistakes, because if you do, you are promoting someone who has never done anything. - The Father of Growth Investing On March 08, 2018, the shares of Sangamo Therapeutics , a gene-editing bioscience, traded slightly up by $0.40 at $25.80.

    Comment?

  2. Belimumab and low-doses of mycophenolate mofetil as induction therapy ...Read the original story w/Photo

    Mar 6, 2018 | BioMed Central

    The treatment of Lupus Nephritis is an unmet need in the management of patients with Systemic Lupus Erythematosus . We report two cases of women affected by Lupus Nephritis ISN/RNP Class IV with serological active disease, high disease activity and marked fatigue.

    Comment?

  3. Systemic Juvenile Idiopathic Arthritis Treatment Market to Reap Excessive Revenues by 2025Read the original story w/Photo

    Mar 8, 2018 | SBWire

    Systemic juvenile idiopathic arthritis, also termed as systemic-onset juvenile idiopathic arthritis, is a specific form of juvenile idiopathic arthritis. SJIA was also known as Still's disease.

    Comment?

  4. Mobilization of hematopoietic stem cells as a result of innate...Read the original story

    Mar 5, 2018 | Leukemia

    Thank you for visiting nature.com. You are using a browser version with limited support for CSS.

    Comment?

  5. Antibiotics influence cancer treatment efficacyRead the original story

    Mar 3, 2018 | Newkerala.com

    Any negative impact of antibiotics on cancer treatment appears to go back to the gut and to whether the microbiota is needed to help activate the T cells driving treatment response, said Dr Gang Zhou, in a study conducted at Medical College of Georgia at Augusta University. Antibiotic use is known to have a near-immediate impact on our gut microbiota and long-term use may leave us drug-resistant and vulnerable to infection.

    Comment?

  6. Antibiotics may impact cancer treatment efficacyRead the original story

    Mar 3, 2018 | Science Daily

    Antibiotic use is known to have a near-immediate impact on our gut microbiota and long-term use may leave us drug resistant and vulnerable to infection. Now there is mounting laboratory evidence that in the increasingly complex, targeted treatment of cancer, judicious use of antibiotics also is needed to ensure these infection fighters don't have the unintended consequence of also hampering cancer treatment, scientists report.

    Comment?

  7. Antibiotic use may affect efficacy of cancer immunotherapiesRead the original story w/Photo

    Mar 2, 2018 | Medical News

    Antibiotic use is known to have a near-immediate impact on our gut microbiota and long-term use may leave us drug resistant and vulnerable to infection. Now there is mounting laboratory evidence that in the increasingly complex, targeted treatment of cancer, judicious use of antibiotics also is needed to ensure these infection fighters don't have the unintended consequence of also hampering cancer treatment, scientists report.

    Comment?

  8. Antibiotics may impact cancer treatment efficacyRead the original story w/Photo

    Mar 2, 2018 | PhysOrg Weblog

    There is mounting laboratory evidence that in the increasingly complex, targeted treatment of cancer, judicious use of antibiotics also is needed to ensure these infection fighters don't have the unintended consequence of also hampering cancer treatment, scientists report. Pictured are Drs.

    Comment?

  9. Functional screening of FGFR4-driven tumorigenesis identifies...Read the original story

    Feb 28, 2018 | Oncogene

    Thank you for visiting nature.com. You are using a browser version with limited support for CSS.

    Comment?

  10. Immune-enhancing activity of C. militaris fermented with Pediococcus...Read the original story w/Photo

    Feb 22, 2018 | BioMed Central

    Cordyceps militaris is reported to exert various immune-activities. To enhance its activity, we fermented C.militaris with Pediococcus pentosaceus ON89A .

    Comment?

  11. A randomized, placebo-controlled pilot trial of aprepitant combined...Read the original story

    Feb 20, 2018 | Bone Marrow Transplantation

    Thank you for visiting nature.com. You are using a browser version with limited support for CSS.

    Comment?

  12. Aurinia Pharmaceuticals: Will AURORA Light The Way To Voclosporin's Approval?Read the original story w/Photo

    Feb 16, 2018 | Seeking Alpha

    As many as 500,000 patients suffer from Systemic Lupus Erythematosus ) in the USA, 60% of whom will develop Lupus Nephritis ) and there are no licenced treatments. Aurinia Pharmaceuticals' AURA study was the most successful Phase 2 study in LN with complete renal response rates of 49.4% in Voclosporin treated patients vs 23.9% of control patients.

    Comment?

  13. Closed Drug Transfer Systems Market to Reflect Impressive Growth Rate Forecast to 2017-2025Read the original story w/Photo

    Feb 15, 2018 | SBWire

    Closed drug transfer systems are defined as drug transfer devices that prohibit the transfer of environmental contaminants into the system and release the hazardous vapor concentrations outside the system. The system is used to transfer hazardous drugs from one receptacle to another without being exposed to outside environment and to the person who is working on it.

    Comment?

  14. Myeloablative Autologous Stem-Cell Transplantation for Severe SclerodermaRead the original story

    Feb 10, 2018 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Scleroderma is a life-threatening autoimmune disease in need of more effective treatment.

    Comment?

  15. Soft chemotherapy is very effective in older patients when added to...Read the original story w/Photo

    Feb 10, 2018 | PhysOrg Weblog

    Avoidance of side-effects of chemotherapy is particularly important in the elderly, but finding the balance between reduced toxicity and maximum effectiveness is not always easy. A trial carried out by the European Organisation for Research and Treatment of Cancer, published today in The Lancet Oncology , shows that, in older patients with HER2 positive metastatic breast cancer , a combination of a 'soft' chemotherapy with antiHER2 therapy is highly active and has low toxicity, important in a frail population.

    Comment?

  16. Fanconi anaemia and cancer: an intricate relationshipRead the original story

    Jan 29, 2018 | Nature Reviews Cancer

    Thank you for visiting nature.com. You are using a browser version with limited support for CSS.

    Comment?

  17. Axicabtagene Ciloleucel Car T-Cell Therapy in Refractory Large B-Cell LymphomaRead the original story

    Feb 6, 2018 | CiteULike

    BACKGROUND In a phase 1 trial, axicabtagene ciloleucel , an autologous anti-CD19 chimeric antigen receptor T-cell therapy, showed efficacy in patients with refractory large B-cell lymphoma after the failure of conventional therapy. METHODS In this multicenter, phase 2 trial, we enrolled 111 patients with diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma, or transformed follicular lymphoma who had refractory disease despite undergoing recommended prior therapy.

    Comment?

  18. Immunosuppressive therapy for steroid-resistant nephrotic syndrome: a ...Read the original story

    Feb 3, 2018 | CiteULike

    The purpose of this study was to conduct a meta-analysis examining the efficacy of cyclophosphamide, cyclosporin, and tacrolimus in treating steroid resistant nephrotic syndrome. Medline, Cochrane, EMBASE, and Google Scholar were searched until May 02, 2017 using the keywords: immunosuppressive therapy, steroid-resistant nephrotic syndrome, cyclophosphamide, cyclosporine A, and tacrolimus.

    Comment?

  19. Comparative effectiveness and tolerance of immunosuppressive...Read the original story

    Feb 3, 2018 | CiteULike

    Immunosuppressive agents in general are shown to prevent renal progression and all-cause mortality in idiopathic membranous nephropathy patients with nephrotic syndrome. However, the efficacy and safety of different immunosuppressive treatments have not been systematic assessed and compared.

    Comment?

  20. Safety of Rituximab Compared with Steroids and Cyclophosphamide for...Read the original story

    Feb 3, 2018 | CiteULike

    To insert individual citation into a bibliography in a word-processor, select your preferred citation style below and drag-and-drop it into the document. Guidelines recommend steroid plus cyclical cyclophosphamide therapy for patients with idiopathic membranous nephropathy at high risk of progression to ESRD.

    Comment?